BREAKING: The DOJ will allow the $69 billion CVS-Aetna deal to proceed.
Wednesday, October 10, 2018
 

BREAKING: CVS-Aetna Merger Secures DOJ Approval, With Strings Attached

The Department of Justice announced Wednesday that it will allow the $69 billion CVS-Aetna deal to proceed.

Aetna's plan to sell its Medicare Part D business to WellCare Health Plans has satisfied federal regulators.

The DOJ made the sale to WellCare a condition of the CVS-Aetna deal moving forward.

"The divestitures required here allow for the creation of an integrated pharmacy and health benefits company that has the potential to generate benefits by improving the quality and lowering the costs of the healthcare services that American consumers can obtain," Assistant Attorney General Makan Delrahim of the DOJ's Antitrust Division said in a statement. [Read the full story...]

 

 

Related stories:

Why Health Systems Should Worry About Walgreens and CVS
WellCare to Buy Aetna's Part D Plans Ahead of CVS Deal
Cigna–Express Scripts Merger Clears DOJ Antitrust Review
AMA Asks DOJ to Block CVS-Aetna Deal
CVS Beats Q2 Expectations Ahead of Planned Aetna Purchase